Citations

Showing 10 of 108083 citations.

Comparison of Posterior Cruciate Ligament Reconstruction Using an All-Inside Technique With and Without Independent Suture Tape Reinforcement
Therrien, Érik , Pareek, Ayoosh , Song, Bryant M. , Wilbur, Ryan R. , Till, Sara E., Levy, Bruce A. , Krych, Aaron J. , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | November 29, 2022 | Volume: 10 | Issue: 11 | Pages: No page available

10.1177/23259671221137357 | PMID 36479468 Get It

Background: Biomechanical studies support the use of suture tape reinforcement for limiting graft elongation and increasing strength in knee ligament reconstructions. Purpose: To compare posterior cruciate ligament (PCL) laxity, complication and reoperation rates, and patient-reported outcomes (PROs) after all-inside single-bundle PCL reconstruction (PCLR) with versus without independent suture tape reinforcement. Study Design: Cohort study; Level of evidence, 3. Methods: A retrospective cohort study of consecutive patients who underwent primary, all-inside allograft single-bundle PCLR with and without independent suture tape reinforcement at a single academic institution from 2012 to 2019. Medical records were reviewed for patient characteristics, additional injuries, and concomitant procedures. PRO scores (including the International Knee Documentation Committee [IKDC], Tegner activity scale, and Lysholm scores), bilateral comparison kneeling radiographs, and physical examination findings were collected at a minimum of 2 years postoperatively. Results: Included were 50 patients: 19 with suture tape reinforcement (mean age 30.6 ± 2.9 years) and 31 without suture tape reinforcement (control group; mean age 26.2 ± 1.6 years). One PCLR graft in the suture tape group failed. Posterior drawer examination revealed grade 1+ laxity in 4 of 19 (21%) of the suture tape cohort versus 6 of 31 (19%) of the control cohort ( P > .999). Bilateral kneeling radiographs showed similar side-to-side differences in laxity between the groups (suture tape vs control: mean, 1.9 ± 0.4 vs 2.6 ± 0.6 mm; P = .361). There were no statistically significant differences between the groups in postoperative IKDC (suture tape vs control: 79.3 vs 79.6; P = .779), Lysholm (87.5 vs 84.3; P = .828), or Tegner activity (5.6 vs 5.7; P = .562) scores. Conclusion: All-inside single-bundle PCLR with and without independent suture tape reinforcement demonstrated low rates of graft failure, complications, and reoperations, with satisfactory PROs at a minimum 2-year follow-up. Radiographic posterior tibial translation was comparable between the 2 groups.
Regional pedicled flap salvage options for large head and neck defects: The old, the new, and the forgotten
Chang, Brent A. , Horwich, Peter , Hayden, Richard E. , Horwich, Peter M , Nathan, Cherie-Ann O , Chang, Brent A , Asarkar, Ameya A

Mayo Clinic

Laryngoscope Investigative Otolaryngology | November 29, 2022 | Volume: 8 | Issue: 1 | Pages: 63-75

10.1002/lio2.983 | PMID 36846409 Get It

AbstractObjectivesThe objective of this article is to review options for regional pedicled reconstruction for large head and neck defects in a salvage setting.MethodsRelevant regional pedicled flaps were identified and reviewed. Expert opinion and supporting literature were used to summarize and describe the available options.ResultsSpecific regional pedicled flap options are presented including the pectoralis major flap, deltopectoral flap, supraclavicular flap, submental flap, latissimus flap, and trapezius flap.ConclusionsRegional pedicled flaps are useful options in a salvage setting even for large defects and should be in the armamentarium of any reconstructive head and neck surgeon. Each flap option carries specific characteristics and considerations.
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding
Wu, Jianfeng , Initiative, for the Alzheimer’s Disease Neuroimaging, Zhu, Wenhui , Mallak, Negar Jalili , Leporé, Natasha , Reiman, Eric M. , Caselli, Richard J., Thompson, Paul M. , Thompson, Paul M , Initiative, for the Alzheimer’s Disease Neuroimaging, Su, Yi , Caselli, Richard J. , Chen, Kewei , Wang, Yalin

Mayo Clinic

Journal of Alzheimer's Disease | November 29, 2022 | Volume: 91 | Issue: 2 | Pages: 637-651

10.3233/jad-220812 | PMID 36463452 Get It

Background: Amyloid-β (Aβ) plaques and tau protein tangles in the brain are the defining ‘A’ and ‘T’ hallmarks of Alzheimer’s disease (AD), and together with structural atrophy detectable on brain magnetic resonance imaging (MRI) scans as one of the neurodegenerative (‘N’) biomarkers comprise the “ATN framework” of AD. Current methods to detect Aβ/tau pathology include cerebrospinal fluid (invasive), positron emission tomography (PET; costly and not widely available), and blood-based biomarkers (promising but mainly still in development). Objective: To develop a non-invasive and widely available structural MRI-based framework to quantitatively predict the amyloid and tau measurements. Methods: With MRI-based hippocampal multivariate morphometry statistics (MMS) features, we apply our Patch Analysis-based Surface Correntropy-induced Sparse coding and max-pooling (PASCS-MP) method combined with the ridge regression model to individual amyloid/tau measure prediction. Results: We evaluate our framework on amyloid PET/MRI and tau PET/MRI datasets from the Alzheimer’s Disease Neuroimaging Initiative. Each subject has one pair consisting of a PET image and MRI scan, collected at about the same time. Experimental results suggest that amyloid/tau measurements predicted with our PASCP-MP representations are closer to the real values than the measures derived from other approaches, such as hippocampal surface area, volume, and shape morphometry features based on spherical harmonics. Conclusion: The MMS-based PASCP-MP is an efficient tool that can bridge hippocampal atrophy with amyloid and tau pathology and thus help assess disease burden, progression, and treatment effects.
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study
Sullivan, Kevin , Griswold, Michael , Ghelani, Kunali, Rajesh, Aishwarya , Shrestha, Srishti , Windham, B. Gwen , Sullivan, Kevin J , Gottesman, Rebecca F. , Knopman, David S. , Mosley, Thomas H.

Mayo Clinic

Journal of Alzheimer's Disease | November 29, 2022 | Volume: 91 | Issue: 2 | Pages: 543-549

10.3233/jad-220746 | PMID 36463445 Get It

At visit 3 (1993–1995) of the ARIC Study, 1.5T brain MRI was completed in 1,881 stroke-free participants (Mean age = 62.9±4.9, 50% Black). Cox regression examined associations between infarct group [infarct-free (referent; n = 1,611), smaller only (<3 mm; n = 50), larger only (≥3 mm but <20 mm; n = 185), both (n = 35)] and up to 25-year incident dementia (n = 539). Participants with both infarcts were over 2.5 times more likely to develop dementia [HR = 2.61; 95% CI = 1.44, 4.72]. Smaller only (HR = 1.22; 95% CI = 0.70, 2.13) and larger only (HR = 1.27; 95% CI = 0.92, 1.74) groups showed associations with wide confidence intervals, unsupported statistically. A late midlife infarct profile including smaller and larger infarcts may represent particular vulnerability to dementia risk.
A Fluke Diagnosis
Ahamed, Summaiyya Hanum, Ho, Jennifer , Ho, Jennifer, Venkatesh, Sudhakar K.

Mayo Clinic

Annals of the Academy of Medicine, Singapore | November 29, 2022 | Volume: 42 | Issue: 7 | Pages: 368-370

10.47102/annals-acadmedsg.v42n7p368 Get It

Prevalence, pathophysiology, prediction and health-related quality of life of long COVID: study protocol of the longitudinal multiple cohort CORona Follow Up (CORFU) study
Ghossein‐Doha, Chahinda , Wintjens, Marieke S. J. N. , Janssen, Emma B N J , Klein, Dorthe O. , Heemskerk, Stella C M , Asselbergs, Folkert W. , Birnie, Erwin , Bonsel, Gouke J. , Bussel, Bas C. T. van , Cals, Jochen , Haagsma, Juanita A. , Hemmen, Bena , Kietselaer, Bas , Linschoten, Marijke , Santen, Susanne van, Vernooy, Kevin , Willems, Loes H. , Westerborg, Rosa, Warlé, Michiel C. , Klein, Dorthe , van Bussel, Bas C T , Cals, Jochen W L , van der Horst, Iwan C C , Kietselaer, Bastiaan L J H, van Kuijk, Sander M J , Kietselaer, Bas L J H , Cate, Hugo Ten , Klok, Frederikus Albertus , Kruif, Martijn D. de

Mayo Clinic

BMJ Open | November 29, 2022 | Volume: 12 | Issue: 11 | Pages: e065142

10.1136/bmjopen-2022-065142 | PMID 36446465 Get It

Introduction The variety, time patterns and long-term prognosis of persistent COVID-19 symptoms (long COVID-19) in patients who suffered from mild to severe acute COVID-19 are incompletely understood. Cohort studies will be combined to describe the prevalence of long COVID-19 symptoms, and to explore the pathophysiological mechanisms and impact on health-related quality of life. A prediction model for long COVID-19 will be developed and internally validated to guide care in future patients. Methods and analysis Data from seven COVID-19 cohorts will be aggregated in the longitudinal multiple cohort CORona Follow Up (CORFU) study. CORFU includes Dutch patients who suffered from COVID-19 at home, were hospitalised without or with intensive care unit treatment, needed inpatient or outpatient rehabilitation and controls who did not suffer from COVID-19. Individual cohort study designs were aligned and follow-up has been synchronised. Cohort participants will be followed up for a maximum of 24 months after acute infection. Next to the clinical characteristics measured in individual cohorts, the CORFU questionnaire on long COVID-19 outcomes and determinants will be administered digitally at 3, 6, 12, 18 and 24 months after the infection. The primary outcome is the prevalence of long COVID-19 symptoms up to 2 years after acute infection. Secondary outcomes are health-related quality of life (eg, EQ-5D), physical functioning, and the prevalence of thromboembolic complications, respiratory complications, cardiovascular diseases and endothelial dysfunction. A prediction model and a patient platform prototype will be developed. Ethics and dissemination Approval was obtained from the medical research ethics committee of Maastricht University Medical Center+ and Maastricht University (METC 2021-2990) and local committees of the participating cohorts. The project is supported by ZonMW and EuroQol Research Foundation. Results will be published in open access peer-reviewed scientific journals and presented at (inter)national conferences. Trial registration number NCT05240742 .
JCEM Case Reports: A New Journal for Clinicians
Young, William F. , Young, W F

Mayo Clinic

JCEM Case Reports | November 29, 2022 | Volume: 1 | Issue: 1 | Pages: No page available

10.1210/jcemcr/luac001 | PMID 37908252 Get It

Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions
Peters, Anthony E. , Borlaug, Barry A. , Sweitzer, Nancy K. , Kitzman, Dalane W. , Mentz, Robert J. , Borlaug, Barry A , Mentz, Robert J , Tromp, Jasper , Shah, Sanjiv J , Lam, Carolyn S.P. , Lewis, Gregory D. , Sharma, Kavita , Pandey, Ambarish

Mayo Clinic

Cardiovascular Research | November 29, 2022 | Volume: 118 | Issue: 18 | Pages: 3403-3415

10.1093/cvr/cvac179 | PMID 36448685 Get It

Abstract Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity with complex pathophysiology and manifestations. Phenomapping is the process of applying statistical learning techniques to patient data to identify distinct subgroups based on patterns in the data. Phenomapping has emerged as a technique with potential to improve the understanding of different HFpEF phenotypes. Phenomapping efforts have been increasing in HFpEF over the past several years using a variety of data sources, clinical variables, and statistical techniques. This review summarizes methodologies and key takeaways from these studies, including consistent discriminating factors and conserved HFpEF phenotypes. We argue that phenomapping results to date have had limited implications for clinical care and clinical trials, given that the phenotypes, as currently described, are not reliably identified in each study population and may have significant overlap. We review the inherent limitations of aggregating and utilizing phenomapping results. Lastly, we discuss potential future directions, including using phenomapping to optimize the likelihood of clinical trial success or to drive discovery in mechanisms of the disease process of HFpEF.
Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy
Myers, Amanda A. , Frank, Igor, Shah, Paras , Tarrell, Robert F., Baird, Bryce , Dora, Chandler , Karnes, R. Jeffrey , Thompson, R. Houston, Tollefson, Matthew K. , Boorjian, Stephen A. , Lyon, Timothy D. , Myers, Amanda , Dora, Chandler D , Lyon, Timothy D

Mayo Clinic

Journal of Urology | November 29, 2022 | Volume: 209 | Issue: 3 | Pages: 525-531

10.1097/ju.0000000000003094 | PMID 36445045 Get It

Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
Burch, Henry B. , Cooper, David S. , Dolman, Peter J. , Leung, Angela M. , Mombaerts, Ilse , Stan, Marius N. , Stan, Marius N , Leung, Angela M , Perros, Petros , Bednarczuk, Tomasz , Salvi, Mario

Mayo Clinic

European Thyroid Journal | November 29, 2022 | Volume: 11 | Issue: 6 | Pages: No page available

10.1530/etj-22-0189 | PMID 36479875 Get It

Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this Consensus Statement.